|
Market Closed -
London S.E.
12:07:39 2026-04-16 EDT
|
5-day change | 1st Jan Change | ||
| 268.40 SEK | +25.07% |
|
+19.82% | +43.02% |
| 10-13 | Nordea reiterates buy on Bonesupport, sees underestimated growth potential | FW |
| 10-12 | Lancelot Sverige rose 2.0 percent in September, positive study results for Bonesupport | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BONESUPPORT HOLDING AB | Biopharmaceuticals | +25.07% | +19.82% | +43.02% | +2.60% | +562.65% | 1.64B |
-
|
-
|
-
|
- Stock Market
- Stocks
- BONEX Stock
- 0RQO Stock
- Charts Bonesupport Holding AB
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
